Houston, TXNCT03407469Now EnrollingIRB Ready

Cancer-related Venous Thromboembolism Clinical Trial in Houston, TX

Access cutting-edge cancer-related venous thromboembolism treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access cancer-related venous thromboembolism specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related cancer-related venous thromboembolism treatment provided free

Apply for This Houston Location

Check if you qualify for this cancer-related venous thromboembolism clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Cancer-related Venous Thromboembolism Study in Houston

The goal of this research study is to learn about the quality of life, experiences with treatment, and healthcare costs of patients who are receiving long-term treatment for venous thromboembolism (VTE) that is related to cancer. This is an investigational study. Up to 260 participants will be enrolled in this multicenter study. Up to 170 will take part in MD Anderson.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Adult (≥ 18 years) female or male subjects.
Confirmed symptomatic proximal or distal lower extremity deep venous thrombosis with or without pulmonary embolism or other venous thromboses. For a symptomatic lower extremity deep venous thrombosis confirmed by compression ultrasonography, venography, or specific computerized tomography (CT) venography, or a thrombus detected in the iliac veins on an abdominal or pelvic CT. For symptomatic pulmonary embolism confirmed by computerized tomographic pulmonary angiography, ventilation perfusion scan, or catheter pulmonary angiography.
Cancer (other than basal-cell or squamous-cell carcinoma of the skin), either active or diagnosed within 2 years prior to VTE. The diagnosis of cancer must be objectively documented by histopathologic diagnosis.
Intention for long-term treatment (at least 3 months) with anticoagulation.
Participants will be enrolled in the study within the first 5 days from initiation of anticoagulation.
Able to provide informed consent and complete study survey tools
Able to read and speak English.

Exclusion Criteria

Indication for anticoagulation other than cancer-related VTE.
An Eastern Cooperative Oncology Group (ECOG) Performance Status of 4 at the time of study enrollment.
Life expectancy \< 3 months.
Isolated pulmonary embolism, or isolated upper extremity deep venous thrombosis, or isolated splanchnic venous thrombosis, or isolated cerebral venous thrombosis confirmed by compression ultrasonography, venography, or CT.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT03407469) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cancer-related Venous Thromboembolism Treatment Options in Houston, TX

If you're searching for cancer-related venous thromboembolism treatment options in Houston, TX, this clinical trial (NCT03407469) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer-related venous thromboembolism specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cancer-related venous thromboembolism clinical trials near you to find additional studies recruiting in your area.

More Deep Vein Thrombosis Trials in Houston, TX

See all deep vein thrombosis clinical trials recruiting in Houston — not just this study.

Browse Deep Vein Thrombosis Trials in Houston →

Browse More Trials by Condition

Deep Vein Thrombosis TrialsErectile Dysfunction TrialsVenous Thromboembolism TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX